NCT04534231 is a clinical trial of Nicotine patch in Tobacco Use Cessation, sponsored by Centre for Addiction and Mental Health.

Who is sponsoring NCT04534231?

NCT04534231 is sponsored by Centre for Addiction and Mental Health.

What drugs are being tested in NCT04534231?

Interventions in NCT04534231: Nicotine patch.

What condition does NCT04534231 study?

NCT04534231 studies Tobacco Use Cessation.

Is NCT04534231 still recruiting?

NCT04534231 is currently completed. Last updated 31 August 2021.

Last reviewed 2021-08-31 · How we verify

NCT04534231

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Offering Nicotine Patches to All Households in a Municipality With High Smoking Rates

Completed Last updated 31 August 2021

What this trial tests

trial testing Nicotine patch in Tobacco Use Cessation in 123 participants. Completed in 30 August 2021.

Timeline

19 October 2020

Primary endpoint
30 August 2021

30 August 2021

Quick facts

Lead sponsor	Centre for Addiction and Mental Health
Status	Completed
Study type	OBSERVATIONAL
Enrollment	123
Start date	19 October 2020
Primary completion	30 August 2021
Estimated completion	30 August 2021
Sites	1 location across Canada

Drugs / interventions tested

Nicotine patch (nicotine-patch) — full drug profile →

Conditions studied

Tobacco Use Cessation — all drugs for Tobacco Use Cessation →

Sponsor

Centre for Addiction and Mental Health — full company profile →

Who can join

18 and older, any sex, with Tobacco Use Cessation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

One municipality with high smoking rates will be selected. A coupon for free-of-charge nicotine patches will be sent to each household. Reductions in the number of people smoking in the chosen municipality from before to after the NRT distribution will be estimated

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Offering nicotine patches to all households in a community with high smoking rates: Pilot test of a population-based approach to promote tobacco cessation.
Cunningham JA, Leatherdale ST, Chaiton M, Tyndale RF, et al · · 2021 · cited 2× · PMID 34007899 · DOI 10.23889/ijpds.v6i1.1400
Investigating if changing the wording of a study invitation letter increased recruitment in a project promoting tobacco cessation in a town with high smoking rates.
Schell C, Godinho A, Cunningham JA. · · 2026 · PMID 41593728 · DOI 10.1186/s13011-026-00704-x
Concentrated Distribution of Nicotine Patches to a Town With High Smoking Rates-Any Evidence of Large Impacts on Tobacco Cessation?
Cunningham JA, Leatherdale ST, Chaiton M, Tyndale RF, et al · · 2023 · PMID 36264570 · DOI 10.1093/ntr/ntac244

Verify or expand the search:

Other trials of Nicotine patch

Trials testing the same drug.

NCT07250230 — Effect of Perioperative High-dose Transdermal Nicotine Patch on Pain Sensitivity Among Male Abstinent Tobacco Smokers Un · NA · recruiting
NCT06053567 — Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity. · Phase 3 · recruiting
NCT05413122 — Evaluating Smoking Cessation Interventions for PWH in South Africa · Phase 2, PHASE3 · recruiting
NCT05487807 — Adapting and Evaluating a Tobacco Use Cessation Program for People Living With HIV in Uganda and Zambia · Phase 1 · recruiting
NCT05351606 — Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya · Phase 4 · completed

Other recruiting trials for Tobacco Use Cessation

Currently open trials in the same condition.

NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
NCT07148232 — Extended Intervention for Tobacco Use (EXIT) for People Experiencing Homelessness · Phase 4 · recruiting
NCT07020273 — CONNECT Cancer Survivors With Tobacco Treatment · NA · recruiting
NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting
NCT06881069 — Reach Through Equitable Implementation in Utah · NA · recruiting

Other Centre for Addiction and Mental Health trials

Trials by the same sponsor.

NCT07211438 — Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression · Phase 2 · not yet recruiting
NCT07146633 — Efficacy of an EMDR App for PTSD and SUD · NA · recruiting
NCT07228923 — Development and Evaluation of a Theory and Evidence-based Intervention to Reduce Hazardous Alcohol Consumption Among Tre · NA · not yet recruiting
NCT07105449 — THC Titration of High-Potency Cannabis Concentrates · NA · not yet recruiting
NCT06928935 — Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04534231 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre for Addiction and Mental Health
Last refreshed: 31 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04534231.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing